Get the Stockscreener App
3.64
3.41%
0.12
Oncology Institute Inc stock is traded at $3.64, with a volume of 702.94K.
It is up +3.41% in the last 24 hours and up +16.67% over the past month.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.
See More
Previous Close:
$3.52
Open:
$3.49
24h Volume:
702.94K
Relative Volume:
0.32
Market Cap:
$358.11M
Revenue:
$361.07M
Net Income/Loss:
$-71.54M
P/E Ratio:
-4.6076
EPS:
-0.79
Net Cash Flow:
$-47.97M
1W Performance:
+4.00%
1M Performance:
+16.67%
6M Performance:
+62.50%
1Y Performance:
+1,269%
1-Day Range:
$3.435
$3.67
1-Week Range:
$3.225
$3.67
52-Week Range:
$0.25
$4.88
Oncology Institute Inc Stock (TOI) Company Profile
Name
Oncology Institute Inc
Sector
Industry
Phone
562-735-3226
Address
18000 STUDEBAKER RD, CERRITOS
Compare TOI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TOI
Oncology Institute Inc
|
3.64 | 346.30M | 361.07M | -71.54M | -47.97M | -0.79 |
|
HCA
Hca Healthcare Inc
|
477.13 | 108.18B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
200.60 | 17.38B | 20.69B | 2.40B | 1.55B | 15.62 |
|
UHS
Universal Health Services Inc
|
227.64 | 14.19B | 16.08B | 1.20B | 1.06B | 17.82 |
|
FMS
Fresenius Medical Care Ag Adr
|
24.11 | 13.94B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
EHC
Encompass Health Corp
|
107.52 | 10.78B | 5.51B | 494.70M | 386.40M | 4.84 |
Oncology Institute Inc Stock (TOI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-25-25 | Initiated | Needham | Buy |
| Jul-23-25 | Initiated | Noble Capital Markets | Outperform |
| Jul-16-25 | Initiated | B. Riley Securities | Buy |
| May-15-25 | Initiated | BTIG Research | Buy |
| Feb-26-24 | Resumed | Jefferies | Buy |
| Sep-14-22 | Initiated | Guggenheim | Buy |
| Aug-15-22 | Initiated | Jefferies | Buy |
View All
Oncology Institute Inc Stock (TOI) Latest News
Can The Oncology Institute Inc. Equity Warrant stock sustain free cash flow growth2025 Dividend Review & Technical Entry and Exit Tips - Улправда
Will The Oncology Institute Inc. Equity Warrant stock reach Wall Street targetsJuly 2025 Recap & Expert Approved Trade Ideas - Улправда
Will The Oncology Institute Inc. stock gain from government policiesMarket Growth Report & Momentum Based Trading Signals - Улправда
Is The Oncology Institute Inc. Equity Warrant stock a top pick in earnings seasonJuly 2025 Action & Low Risk Profit Maximizing Plans - Улправда
How institutional buying supports The Oncology Institute Inc. stockEarnings Trend Report & Weekly Momentum Stock Picks - Bölüm Sonu Canavarı
How The Oncology Institute Inc. Equity Warrant stock reacts to oil pricesPortfolio Growth Summary & Weekly Market Pulse Updates - Улправда
Take Profit: Will The Oncology Institute Inc. Equity Warrant stock benefit from infrastructure spending2025 Price Action Summary & Technical Pattern Alert System - ulpravda.ru
The Caris Precision Oncology Alliance Welcomes Providence Swedish Cancer Institute - Sahm
Will The Oncology Institute Inc. stock gain from strong economyJuly 2025 Pullbacks & Smart Allocation Stock Reports - DonanımHaber
Is The Oncology Institute Inc. stock a buy before product launchesQuarterly Market Review & Weekly High Return Opportunities - DonanımHaber
How The Oncology Institute Inc. Equity Warrant stock performs in stagflationShare Buyback & Fast Gain Swing Trade Alerts - DonanımHaber
Update Recap: How The Oncology Institute Inc. Equity Warrant stock reacts to oil pricesJuly 2025 Intraday Action & Consistent Profit Focused Trading Strategies - Улправда
Will The Oncology Institute Inc. Equity Warrant stock keep outperforming rivalsMarket Performance Report & Daily Technical Forecast Reports - DonanımHaber
The Oncology Institute: Making Progress (NASDAQ:TOI) - Seeking Alpha
Is The Oncology Institute Inc. stock supported by strong fundamentals2025 Pullback Review & Community Consensus Trade Signals - Улправда
Brad Hively Sells 13,333 Shares of Oncology Institute (NASDAQ:TOI) Stock - MarketBeat
Oncology Institute Director Sells Shares to Cover Tax Liabilities - TradingView — Track All Markets
Officer/Dir Hively Surrenders 13,333 Of Oncology Institute Inc [TOI] - TradingView — Track All Markets
TOI (NASDAQ: TOI) notice covers planned Rule 144 sale of 13,333 shares - Stock Titan
MSN Money - MSN
Wall Street analysts’ outlook for Oncology Institute Inc (TOI) - setenews.com
Can The Oncology Institute Inc. Equity Warrant stock deliver strong Q4 earnings2025 Short Interest & Growth Focused Entry Point Reports - Newser
How The Oncology Institute Inc. Equity Warrant stock compares to market leadersMarket Sentiment Report & Weekly Sector Rotation Insights - Newser
TOIIW SEC FilingsThe Oncology Institute Inc 10-K, 10-Q, 8-K Forms - Stock Titan
This trade activity should not be overlooked: Oncology Institute Inc (TOI) - setenews.com
The Caris Precision Oncology Alliance Welcomes UAMS Winthrop P. Rockefeller Cancer Institute - Yahoo Finance
Why The Oncology Institute Inc. Equity Warrant stock could benefit from AI revolutionPortfolio Profit Report & AI Based Buy/Sell Signal Reports - Newser
Is The Oncology Institute Inc. Equity Warrant stock a safe investment in uncertain marketsQuarterly Performance Summary & High Accuracy Swing Entry Alerts - Newser
Oncology Institute Announces Board Member Resignation - TipRanks
Oncology Institute Announces Board Resignation - TradingView
Oncology Institute director Gabe Ling resigns - TipRanks
The Oncology Institute Announces Resignation of Board Member Gabe Ling - The Manila Times
The Oncology Institute announces resignation of board member Gabe Ling - marketscreener.com
Oncology Institute (NASDAQ: TOI) starts search to replace Gabe Ling on board - Stock Titan
What analysts say about The Oncology Institute Inc stockPrice Volatility Patterns & Build a Dividend-Powered Portfolio - earlytimes.in
The Oncology Institute (TOI) Loses 20% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - MSN
US Stocks Recap: Will The Oncology Institute Inc. Equity Warrant stock split again soonWeekly Market Report & Free Real-Time Market Sentiment Alerts - moha.gov.vn
Needham & Company LLC Initiates Coverage on Oncology Institute (NASDAQ:TOI) - Defense World
The Oncology Institute Reports Second Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance - ADVFN
Oncology Institute Projects Strong 2025 Revenue Growth - MSN
The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance - ADVFN
Oncology Institute initiated with a Buy at Needham - MSN
There is no doubt that Oncology Institute Inc (TOI) ticks all the boxes. - Setenews
Needham Initiates Coverage on Oncology Institute With Buy Rating, $5 Price Target - MarketScreener
Oncology Institute (TOI) Gains "Buy" Rating with $5 Price Target by Needham | TOI Stock News - GuruFocus
Needham Initiates Coverage of Oncology Institute (TOI) with Buy Recommendation - Nasdaq
[Form 4] Oncology Institute, Inc. Insider Trading Activity - Stock Titan
Investors Give The Oncology Institute, Inc. (NASDAQ:TOI) Shares A 29% Hiding - simplywall.st
A Mysterious Stock Has Rallied Over 950% This Year. Here's 1 Key Reason Why Investors Are Turning Bullish - The Motley Fool
A Mysterious Stock Has Rallied Over 950% This Year. Here's 1 Key Reason Why Investors Are Turning Bullish - The Globe and Mail
Director’s Major Stock Sale at Oncology Institute! - TipRanks
Oncology Institute Inc Stock (TOI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.71%
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):